These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

556 related articles for article (PubMed ID: 28458536)

  • 1. Protein corona: a new approach for nanomedicine design.
    Nguyen VH; Lee BJ
    Int J Nanomedicine; 2017; 12():3137-3151. PubMed ID: 28458536
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In Situ Characterization of Protein Adsorption onto Nanoparticles by Fluorescence Correlation Spectroscopy.
    Shang L; Nienhaus GU
    Acc Chem Res; 2017 Feb; 50(2):387-395. PubMed ID: 28145686
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nano-Bio Interactions in Cancer: From Therapeutics Delivery to Early Detection.
    Liu Y; Wang J; Xiong Q; Hornburg D; Tao W; Farokhzad OC
    Acc Chem Res; 2021 Jan; 54(2):291-301. PubMed ID: 33180454
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanistic Understanding of Protein Corona Formation around Nanoparticles: Old Puzzles and New Insights.
    Nienhaus K; Nienhaus GU
    Small; 2023 Jul; 19(28):e2301663. PubMed ID: 37010040
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A health concern regarding the protein corona, aggregation and disaggregation.
    Falahati M; Attar F; Sharifi M; Haertlé T; Berret JF; Khan RH; Saboury AA
    Biochim Biophys Acta Gen Subj; 2019 May; 1863(5):971-991. PubMed ID: 30802594
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protein corona, understanding the nanoparticle-protein interactions and future perspectives: A critical review.
    Kopac T
    Int J Biol Macromol; 2021 Feb; 169():290-301. PubMed ID: 33340622
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insights into colloidal nanoparticle-protein corona interactions for nanomedicine applications.
    Martínez-Negro M; González-Rubio G; Aicart E; Landfester K; Guerrero-Martínez A; Junquera E
    Adv Colloid Interface Sci; 2021 Mar; 289():102366. PubMed ID: 33540289
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Understanding the Factors Influencing Chitosan-Based Nanoparticles-Protein Corona Interaction and Drug Delivery Applications.
    Moraru C; Mincea M; Menghiu G; Ostafe V
    Molecules; 2020 Oct; 25(20):. PubMed ID: 33081296
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protein-Nanoparticle Interaction: Corona Formation and Conformational Changes in Proteins on Nanoparticles.
    Park SJ
    Int J Nanomedicine; 2020; 15():5783-5802. PubMed ID: 32821101
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Crown and the Scepter: Roles of the Protein Corona in Nanomedicine.
    Cai R; Chen C
    Adv Mater; 2019 Nov; 31(45):e1805740. PubMed ID: 30589115
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Concentration-dependent protein adsorption at the nano-bio interfaces of polymeric nanoparticles and serum proteins.
    Zhang TX; Zhu GY; Lu BY; Zhang CL; Peng Q
    Nanomedicine (Lond); 2017 Nov; 12(22):2757-2769. PubMed ID: 29017387
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The interaction between nanoparticles-protein corona complex and cells and its toxic effect on cells.
    Liu N; Tang M; Ding J
    Chemosphere; 2020 Apr; 245():125624. PubMed ID: 31864050
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Research progress and application opportunities of nanoparticle-protein corona complexes.
    Huang W; Xiao G; Zhang Y; Min W
    Biomed Pharmacother; 2021 Jul; 139():111541. PubMed ID: 33848776
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma protein adsorption and biological identity of systemically administered nanoparticles.
    Chen D; Ganesh S; Wang W; Amiji M
    Nanomedicine (Lond); 2017 Sep; 12(17):2113-2135. PubMed ID: 28805542
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The curious cases of nanoparticle induced amyloidosis during protein corona formation and anti-amyloidogenic nanomaterials: Paradox or prejudice?
    Randhawa S; Abidi SMS; Dar AI; Acharya A
    Int J Biol Macromol; 2021 Dec; 193(Pt A):1009-1020. PubMed ID: 34728302
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of nanoparticle size and PEGylation on the protein corona of PLGA nanoparticles.
    Partikel K; Korte R; Stein NC; Mulac D; Herrmann FC; Humpf HU; Langer K
    Eur J Pharm Biopharm; 2019 Aug; 141():70-80. PubMed ID: 31082511
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A nanoinformatics decision support tool for the virtual screening of gold nanoparticle cellular association using protein corona fingerprints.
    Afantitis A; Melagraki G; Tsoumanis A; Valsami-Jones E; Lynch I
    Nanotoxicology; 2018 Dec; 12(10):1148-1165. PubMed ID: 30182778
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bypassing Protein Corona Issue on Active Targeting: Zwitterionic Coatings Dictate Specific Interactions of Targeting Moieties and Cell Receptors.
    Safavi-Sohi R; Maghari S; Raoufi M; Jalali SA; Hajipour MJ; Ghassempour A; Mahmoudi M
    ACS Appl Mater Interfaces; 2016 Sep; 8(35):22808-18. PubMed ID: 27526263
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protein corona, influence on drug delivery system and its improvement strategy: A review.
    Guo F; Luo S; Wang L; Wang M; Wu F; Wang Y; Jiao Y; Du Y; Yang Q; Yang X; Yang G
    Int J Biol Macromol; 2024 Jan; 256(Pt 2):128513. PubMed ID: 38040159
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nanoparticles-cell association predicted by protein corona fingerprints.
    Palchetti S; Digiacomo L; Pozzi D; Peruzzi G; Micarelli E; Mahmoudi M; Caracciolo G
    Nanoscale; 2016 Jul; 8(25):12755-63. PubMed ID: 27279572
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.